000 | 01916 a2200601 4500 | ||
---|---|---|---|
005 | 20250517032946.0 | ||
264 | 0 | _c20150713 | |
008 | 201507s 0 0 eng d | ||
022 | _a1476-4687 | ||
024 | 7 |
_a10.1038/nature14407 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFinisguerra, Veronica | |
245 | 0 | 0 |
_aMET is required for the recruitment of anti-tumoural neutrophils. _h[electronic resource] |
260 |
_bNature _cJun 2015 |
||
300 |
_a349-53 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Deletion |
650 | 0 | 4 | _aHepatocyte Growth Factor |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation _ximmunology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aNeutrophils _xdrug effects |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 | _aProto-Oncogene Mas |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-met _xantagonists & inhibitors |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 | _aTransendothelial and Transepithelial Migration |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aDi Conza, Giusy | |
700 | 1 | _aDi Matteo, Mario | |
700 | 1 | _aSerneels, Jens | |
700 | 1 | _aCosta, Sandra | |
700 | 1 | _aThompson, A A Roger | |
700 | 1 | _aWauters, Els | |
700 | 1 | _aWalmsley, Sarah | |
700 | 1 | _aPrenen, Hans | |
700 | 1 | _aGranot, Zvi | |
700 | 1 | _aCasazza, Andrea | |
700 | 1 | _aMazzone, Massimiliano | |
773 | 0 |
_tNature _gvol. 522 _gno. 7556 _gp. 349-53 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/nature14407 _zAvailable from publisher's website |
999 |
_c24911493 _d24911493 |